FIBROTARGET

🔬🔍 Did you know FIBROTARGET is advancing research to better understand and tackle intestinal fibrosis? The project has 5️⃣ publications on biomarkers, innovative lab techniques, and therapies to better understand and target fibrosis. 📖 Read more: loom.ly/oUyA3DU

💭 What’s it like living with fibrosis? Last year, we spoke to Anastasia Ntanou, an IBD advocate from Greece, about her 15+ years living with fibrotic #Crohn’sDisease. Hear her story and the misconceptions she’s faced 🎬 ➡️ Read more: loom.ly/QbZj4WU

Strictures. Pain. Surgery. What is intestinal fibrosis and how is FIBROTARGET tackling it? Fibrosis in IBD causes scarring, pain & obstruction. With 0 approved treatments, FIBROTARGET focuses on improving prevention, diagnosis and treatment. 🌐More: loom.ly/IGYRLgM

🎄Happy Holidays from the FIBROTARGET project! Thank you for your continued support in advancing research on intestinal fibrosis and fibrostenosis. We wish everyone a restful festive break and look forward to sharing more of our project achievements in 2026🎉.

🌟FIBROTARGET Young Talent Spotlight! Meet Lukas Schuster, a PhD student at UK Erlangen studying pathways linked to intestinal fibrosis. He shares his insights and the role of collaboration in driving progress. Learn more here➡️loom.ly/ZDwhLh8

📥Stay informed: sign up for the FIBROTARGET newsletter for the latest in IBD fibrosis research! Clear, accessible insights for researchers, clinicians, patients and the wider community. Join our growing network!➡️ loom.ly/atbot4M

🔍New FIBROTARGET Info Pill! This edition explains biomarkers - measurable signs that help diagnose, monitor and predict IBD activity. By studying these indicators FIBROTARGET aims to improve fibrosis detection and monitoring for better IBD care. More➡️loom.ly/Whlbs78

🚨 Last chance! Join the IFCCA Academy’s 2nd online module with FIBROTARGET: 🎥 Living with Fibrosis: Challenges, Treatments & Innovations Learn about the latest in intestinal fibrosis with expert & patient insights. ⏰ Register by 3 Nov: lnkd.in/ebXVwYpR

🎤 FIBROTARGET at the 3rd International Workshop on Liver & Gut Fibrosis in Valencia! Earlier this month, FIBROTARGET's Gianluca Matteoli (@KU_Leuven) & Elena Ricart (@hospitalclinic) presented, joining experts driving forward fibrosis research. More➡️ loom.ly/Fci-jmY

💡FIBROTARGET at #UEGWeek2025! In Berlin, our session “From bench to bedside in fibrosis innovation” brought together @KU_Leuven, IFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials. More➡️ loom.ly/IGYRLgMM

🌟 Join us at #UEGWeek 2025 in Berlin! FIBROTARGET partners will be there to discuss the latest in fibrosis innovation and patient-centred trial design. Don’t miss the opportunity to connect and explore how we’re advancing research in intestinal fibrosis! #IBD #FibrosisResearch

📣FIBROTARGET will be at #UEGWeek 2025 in Berlin! We’ll share progress on advancing research into intestinal fibrosis and fibrostenosis in Crohn’s disease. Stay tuned for details on where to find us! #UEGWeek #FIBROTARGET #CrohnsDisease #IntestinalFibrosis

🔍 Interested in the latest advances in intestinal fibrosis research? Stay updated with cutting-edge findings, project news & events by signing up for the FIBROTARGET newsletter. Designed for researchers, clinicians & the wider community. Join here ➡️ loom.ly/atbot4M

Looking for reliable info on intestinal fibrosis? The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian! Created with and for the community with @efcca. Download your copy👇 👉 loom.ly/yW8mEBc

Have you heard the news?🎉 FIBROTARGET coordinator Prof Séverine Vermeire is now the first female rector of KU Leuven in 600 years! Prof Gianluca Matteoli takes over as coordinator with Prof Bram Verstockt & FIBROTARGET colleagues across Europe. More➡️ loom.ly/lFmqrcI

📚 Looking for scientific publications on intestinal fibrosis? We’ve updated the FIBROTARGET publications page! Now you can easily browse all peer-reviewed research from the project in one place. 🔗 Explore the page➡️: loom.ly/oUyA3DU #IBDresearch #Fibrosis

🎥 “You are everything else, and you are chronically ill.” Patient advocate Anastasia Ntanou's story is a powerful reminder: being a patient is just one part of who you are. 💬 Read their full story via FIBROTARGET: loom.ly/QbZj4WU #PatientVoices #FibrosisAwareness

📣 New from FIBROTARGET! Can JAK-STAT signalling help treat IBD fibrosis? A new review by KU Leuven explores how this immune pathway - already targeted in IBD - might also reduce fibrosis by acting on fibroblasts. 🔗 Read more: loom.ly/AdfSDxo #IBD #Fibrosis

🌟 Young Talent Spotlight! In this short interview, PhD student Gaia Zanella shares insights into her work, the challenges of studying intestinal fibrosis, and the novel research approaches being explored by FIBROTARGET researchers. 🧪 Read more ➡️ loom.ly/UpoRtJ4

🔍Introducing #FIBROTARGET Info Pills! We’re breaking down key #IBD & #Fibrosis concepts in simple terms—starting with: What is IBD-related fibrosis? 💡 Many hear the word—but what does it actually mean, and how does it influence disease progression? 🌐 loom.ly/391FxNk